Market Research Logo

Bulgaria Pharmaceuticals and Healthcare Report Q2 2015

Bulgaria Pharmaceuticals and Healthcare Report Q2 2015

BMI View: In 2015, we expect the fallout from the banking and NHIF funding crises to impactpharmaceutical and healthcare spending, but given the passage of reforms to healthcare financing, we holda more positive view for the long term development of the pharmaceutical & healthcare sector.

Headline Expenditure Projections

Pharmaceuticals: BGN2.50bn (USD1.71bn) in 2014 to BGN2.41bn (USD1.54bn) in 2015; -3.7% inlocal currency terms and -10.2% in US dollar terms. Forecast revised downwards from Q115.

Healthcare: BGN6.06bn (USD4.14bn) in 2014 to BGN5.81bn (USD3.70bn) in 2015; -4.1% in localcurrency terms and -10.6% in US dollar terms. Forecast revised significantly downwards from Q115.


BMI Industry View
SWOT
Political
Economic
Industry Forecast
Pharmaceutical Market Forecast
Table: Pharmaceutical Sales, Historical Data And Forecasts (Bulgaria 2011-2019)
Healthcare Market Forecast
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Bulgaria 2011-2019)
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Bulgaria 2011-2019)
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Bulgaria 2011-2019)
Prescription Drug Market Forecast
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Bulgaria 2011-2019)
Patented Drug Market Forecast
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Bulgaria 2011-2019)
Generic Drug Market Forecast
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Bulgaria 2011-2019)
OTC Medicine Market Forecast
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Bulgaria 2011-2019)
Pharmaceutical Trade Forecast
Table: Pharmaceutical Trade Data And Forecasts (Bulgaria 2011-2019)
Table: Pharmaceutical Trade Data And Forecasts local currency (Bulgaria 2011-2019)
Key Risks To BMI's Forecast Scenario
Macroeconomic Forecasts
Economic Analysis
Table: GDP By Expenditure (Bulgaria 2011-2018)
Industry Risk Reward Ratings
Central And Eastern Europe Risk/Reward Index
Bulgaria Risk/Reward Index
Rewards
Risks
Market Overview
Industry Trends And Developments
Epidemiology
Table: Cancer Incidence Rates, 2012-2035
Healthcare Sector
Table: Bulgarian Healthcare Resources
Table: Healthcare Activity
Table: Healthcare Personnel
Healthcare Insurance
Healthcare Reform Through To 2020
Reforming The Health Insurance Model
Healthcare Financing
Table: NHIF Budget, 2014
Table: Bulgarian National Health Insurance Fund Revenues (BGN 000s), 2015
Research & Development
Table: Members Of ARPharM, 2014
Clinical Trials
Regulatory Development
Pharmaceutical Advertising
Intellectual Property Environment
Pricing Regime
Recent Pricing Developments
Drug Policy Amendments
Reimbursement Regime
Reimbursement Regime Developments
Competitive Landscape
Pharmaceutical Industry
Pharmaceutical Retail Sector
Wholesale Sector
Table: Pharmaceutical Wholesale And Retail Market, 2009-2012
Company Profile
Sopharma
Biovet
Actavis Bulgaria
GlaxoSmithKline
Novartis
Sanofi
Pfizer
Merck & Co
Demographic Forecast
Table: Population Headline Indicators (Bulgaria 1990-2025)
Table: Key Population Ratios (Bulgaria 1990-2025)
Table: Urban/Rural Population & Life Expectancy (Bulgaria 1990-2025)
Table: Population By Age Group (Bulgaria 1990-2025)
Table: Population By Age Group % (Bulgaria 1990-2025)
Glossary
Methodology
Pharmaceutical Expenditure Forecast Model
Healthcare Expenditure Forecast Model
Notes On Methodology
Risk/Reward Index Methodology
Index Overview
Table: Pharmaceutical Risk/Reward Index Indicators
Indicator Weightings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report